Bio-Rad (BIO) Stock Price
$280.1 0%
to add to portfolio
AI Score

-
Alternative
3 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bio-Rad, AI stock picks, stock alerts and much more.
BIO AI Stock Analysis
AI stock analysis for BIO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bio-Rad (BIO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Bio-Rad (BIO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bio-Rad (BIO), currently trading at $280.1, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BIO

-
Bio-Rad Laboratories, Inc.
-
Symbol
BIO
-
Market
NYSE
-
Industry
Medical - Devices
-
Market Cap
7.9B
Similar Stocks
![]() |
Abbott Laboratories ABT |
$134.9 1.3% |
7 |
![]() |
Boston Scientific BSX |
$104.5 0.8% |
7 |
![]() |
Edwards Lifesciences EW |
$73.3 1.9% |
6 |
![]() |
Medtronic MDT |
$89.94 2.3% |
7 |
![]() |
Stryker SYK |
$382.8 0.9% |
7 |
News
BIO Alternative Data
Web Traffic
Bio-Rad receives an estimated 520695 monthly visitors to bio-rad.com.
-
Web Traffic
520695
-
Change from Previous Month
10.9%
-
3 Month Change
20.3%
-
YoY Change
20.3%
News Mentions
Bio-Rad was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
200%
-
1 Month Change
50%
-
3 Month Change
200%
Reddit Mentions
Bio-Rad has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Facebook Engagement
Bio-Rad has engaged 25 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
25
-
Daily Change
4.2%
-
1 Month Change
13.6%
-
3 Month Change
99.6%
-
YoY Change
99.6%
LinkedIn Followers
412,957 are following Bio-Rad on LinkedIn, up by 0.8% over the last month.
-
LinkedIn Followers
412957
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
2.1%
Job Postings
Bio-Rad has an estimated 116 open job postings, which is down -17.7% over the last month.
-
Job Postings
116
-
Daily Change
0.9%
-
1 Month Change
17.7%
-
3 Month Change
37.3%
-
YoY Change
37.3%
LinkedIn Employees
According to LinkedIn, Bio-Rad has 8,961 employees, up by 0.1% over the last month.
-
LinkedIn Employees
8961
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
1.7%
-
YoY Change
1.7%
Instagram Followers
Bio-Rad has 13,310 Instagram Followers on its main Instagram account, up by 0.9% over the last month.
-
Instagram Followers
13310
-
Daily Change
0.1%
-
1 Month Change
0.9%
-
3 Month Change
3.9%
-
YoY Change
3.9%
Twitter Followers
Bio-Rad has 16,845 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
16845
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Business Outlook
-
Business Outlook
50
-
Change from Previous Month
3.8%
-
3 Month Change
0%
-
YoY Change
0%
BIO Financials
BIO Key Metrics
-
Total Revenue
$649.7M
-
Net Income
$653.2M
-
Earnings per Share
$23.09
-
Free cash flow
$246.7M
-
EBITDA
$1.4B
-
EBITDA Ratio
2.13899
-
Total Assets
$10.6B
BIO 2-year Revenue & Income
BIO 2-year Free Cash Flow
BIO Technicals
BIO SMA
BIO RSI
FAQ
What's the current price of Bio-Rad (BIO) Stock?
The price of an Bio-Rad (BIO) share is $280.1.
What's the market cap of Bio-Rad?
The current market cap of Bio-Rad is 7.9B.
Should I buy or sell BIO?
Bio-Rad shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Bio-Rad is better viewed as a hold or accumulate position while waiting for further developments.
Is Bio-Rad a good investment?
The current analysis of Bio-Rad's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Bio-Rad's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Bio-Rad (BIO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Bio-Rad stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Bio-Rad (BIO) that investors often compare it to?
Bio-Rad (BIO) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.
What is the forecast for Bio-Rad's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bio-Rad's stock price to be around $265.5 in 2026. Starting from the current price of $280.1, this represents a 5.2% change in price, indicating a bearish outlook for the stock.
How to buy Bio-Rad (BIO) Stock?
Bio-Rad stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bio-Rad shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.